| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193775 | Annals of Allergy, Asthma & Immunology | 2006 | 9 Pages |
Abstract
Further research, specifically using sleep measurements as primary end points, is needed to definitively show that intranasal corticosteroids reduce nasal congestion, thereby improving sleep and, consequently, quality of life in patients with allergic rhinitis. These future trials will serve to identify the most effective therapies that target the adverse effects of sleep impairment in this disorder.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Carah B. MS, Ellen L. MD, Chris MS, Jeffery MS, Timothy J. DO,